Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 49CNS 17Genitourinary 13Gynecologic 11Gastrointestinal 11Other solid neoplasm 8Dermatologic 5Lymphoid 4Thoracic 3Other hematologic neoplasm 2Head & Neck 2Plasma cell 1Endocrine 1Breast 1

Conditions

Leukemia, Myeloid, Acute 3510Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Leukemia, Lymphocytic, Chronic, B-Cell 1992Myelodysplastic Syndromes 1412Hematologic Neoplasms 1385Lymphoma 1176Lymphoma, Non-Hodgkin 1079Leukemia, Myelogenous, Chronic, BCR-ABL Positive 863Lymphoma, Follicular 761Multiple Myeloma 739Lymphoma, Mantle-Cell 730Lymphoma, Large B-Cell, Diffuse 714Burkitt Lymphoma 692Lymphoma, B-Cell, Marginal Zone 645Hodgkin Disease 636Recurrence 627Leukemia, Myelomonocytic, Chronic 536Neoplasms 519Lymphoma, Large-Cell, Immunoblastic 451Myeloproliferative Disorders 445Leukemia, Myeloid, Chronic-Phase 437Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 414Congenital Abnormalities 411Waldenstrom Macroglobulinemia 360Blast Crisis 353Leukemia, Myeloid, Accelerated Phase 318Lymphoma, T-Cell, Cutaneous 311Primary Myelofibrosis 297Neoplasms, Plasma Cell 276

Interventions

tanespimycin 1ganitumab 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Desmoplastic Small Round Cell Tumor × Other hematologic neoplasm × Clear all
NCT00562380 2013-07-18

AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
64 enrolled
DermatologicGenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Prostatic Neoplasms, Sarcoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Neuroectodermal Tumors, Primitive, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Desmoplastic Small Round Cell Tumor

NCT00093821 2013-06-04

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
70 enrolled
CNSLymphoidOther hematologic neoplasmSarcoma

Neuroblastoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡